Viva BioInnovator

Summary

Viva BioInnovator is the famous VC, which was founded in 2014. The company was established in Asia in China. The leading representative office of defined VC is situated in the Shanghai.

The typical startup value when the investment from Viva BioInnovator is 5-10 millions dollars. The fund is generally included in 2-6 deals every year. Considering the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. Deals in the range of 1 - 5 millions dollars are the general things for fund. The top activity for fund was in 2017.

The fund has no exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Therapeutics, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Mebias Discovery, Tabomedex Biosciences, Inc., QurAlis. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Viva BioInnovator, startups are often financed by MP Healthcare Venture Management, Amgen Ventures, Alexandria Venture Investments. The meaningful sponsors for the fund in investment in the same round are Sprout BioVentures, MP Healthcare Venture Management, Lumira Ventures. In the next rounds fund is usually obtained by Kaitai Capital.